Ironwood Pharmaceuticals (IRWD) Accounts Payables (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Accounts Payables across 17 years of filings, most recently posting $3.2 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $3.2 million, down 44.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (down 44.45% YoY), and the FY2025 annual result was $2.9 million, up 36.25% from the prior year.
• Accounts Payables came in at $3.2 million for Q1 2026 at Ironwood Pharmaceuticals, up from $2.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $7.8 million in Q4 2023 to a low of $118000.0 in Q1 2023.
• The 5-year median for Accounts Payables is $2.9 million (2025), against an average of $2.8 million.
• Across the five-year window, Accounts Payables sank 77.82% in 2023 and surged 5172.88% in 2024, its largest moves.
• Ironwood Pharmaceuticals' Accounts Payables stood at $483000.0 in 2022, then soared by 1521.12% to $7.8 million in 2023, then sank by 72.84% to $2.1 million in 2024, then surged by 36.25% to $2.9 million in 2025, then advanced by 11.7% to $3.2 million in 2026.
• The last three Accounts Payables figures came in at $3.2 million (Q1 2026), $2.9 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.